|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS11299|
Europe Scar Treatment – Market Overview
The Europe scar treatment market size was valued at $5.2 billion in 2016, which is expected to reach $9.8 billion by 2023, growing at a CAGR of 9.6% during the forecast period (2017-2023). Topical scar treatment is expected to witness highest growth during the forecast period in the European scar treatment market due to increasing disposable income, rising prevalence of chronic wounds and availability of different types of topical scar treatment products. Topical scar treatment is followed by surface scar treatment, laser scar treatment, injectable scar treatment, invasive surgical scar treatment. Among the different types of scar, post-surgical scar was the most widely treated type of scar in Europe in 2016, followed by acne scar, keloid scar & hypertrophic scar, contracture scar, and stretch mark. The contribution of hospital in the European scar treatment market was the highest in 2016 mainly due to continuously developing reimbursement structure in the region.
The prevalence of skin problems is on rise due to rising levels of pollution and ozone depletion which causes direct exposure to UV radiations leading to sunburns and diminished elasticity of skin. The prevalence of wounds is rising in the Europe and so is the disposable income of European households enabling them to opt for cosmetic surgeries and expensive scar treatments available in the market. Due to rising expenditure on personal care in the U.K., various skin treatment product manufacturers are launching advanced products in the country. For instance, in May 2012, Avita Medical developed ReCell Spray-On Skin system for treating chronic wounds, burns and scars in the U.K. The technological advancements and rising awareness about skin related problems and their available treatments are also key factors leading to the growth of the European scar treatment market. For instance, in February 2017, Lumenis Ltd. supported International Scar Treatment Conference in Israel, held in Tel Aviv, focused on spreading awareness about the interdisciplinary approach for successful management of scars. According to the European Wound Management Association (EWMA), around 4 million wound cases are reported every year in the Europe. This in turn, is driving the demand for scar treatment products in the region. Furthermore, according to the OECD, the German household disposable income was $34,887.8 in 2014, compared to $34,286.2 in 2013. The increase in the disposable income enables people to opt for new and expensive treatments, that are available in the market for treating scar. Furthermore, the growing online cosmetic products industry in the region is adding to the growth of the scar treatment market in Europe.
The adverse effects associated with the use of scar treatment products and high cost of these products are hindering the growth of the European scar treatment market.
Europe Scar Treatment – Competitive Landscape
The key players in the European scar treatment market are coming up with scar treatment products with innovative technologies, especially with laser therapy approaches. For instance, in September 2015, Lumenis Ltd. Announced promising clinical data of its advanced laser platform, UltraPulse with SCAAR FX, at the 16th European Burns Association Congress, in Hannover, Germany. Laser scar therapy, especially fractional ablative laser resurfacing, has turned out to be a momentous advancement in scar treatment and management and has been increasingly adopted as a promising approach in the treatment of burns and scars.
Some of the key players operating in the European scar treatment market include Merz GmbH & Company KGAA, Mölnlycke Health Care AB, Smith & Nephew Plc, Syneron Medical Ltd., Lumenis Ltd., L'oreal S.A, H&R Healthcare Ltd., Avita Medical, Arbonne International, and Laverana GmbH & Co.KG.
By Type of Treatment
By Type of Scar
By End User